» Authors » Divya Ramakrishnan

Divya Ramakrishnan

Explore the profile of Divya Ramakrishnan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 55
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lost J, Ashraf N, Jekel L, von Reppert M, Tillmanns N, Willms K, et al.
Neurooncol Adv . 2024 Dec; 6(1):vdae157. PMID: 39659829
Background: Glioma, the most prevalent primary brain tumor, poses challenges in prognosis, particularly in the high-grade subclass, despite advanced treatments. The recent shift in tumor classification underscores the crucial role...
2.
Ramakrishnan D, Farhat L, Vattimo E, Levine J, Johnson J, Artukoglu B, et al.
J Psychiatr Res . 2024 Apr; 173:387-397. PMID: 38598877
Introduction: Expert consensus operationalized treatment response and remission in obsessive-compulsive disorder (OCD) as a Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) reduction ≥35% and score ≤12 with ≤2 on Clinical Global Impressions Improvement...
3.
Ramakrishnan D, Bruningk S, von Reppert M, Memon F, Maleki N, Aneja S, et al.
AJNR Am J Neuroradiol . 2024 Mar; 45(4):475-482. PMID: 38453411
Background And Purpose: Response on imaging is widely used to evaluate treatment efficacy in clinical trials of pediatric gliomas. While conventional criteria rely on 2D measurements, volumetric analysis may provide...
4.
Ramakrishnan D, Jekel L, Chadha S, Janas A, Moy H, Maleki N, et al.
Sci Data . 2024 Feb; 11(1):254. PMID: 38424079
Resection and whole brain radiotherapy (WBRT) are standard treatments for brain metastases (BM) but are associated with cognitive side effects. Stereotactic radiosurgery (SRS) uses a targeted approach with less side...
5.
von Reppert M, Ramakrishnan D, Bruningk S, Memon F, Abi Fadel S, Maleki N, et al.
Neurooncol Adv . 2024 Jan; 6(1):vdad172. PMID: 38221978
Background: Although response in pediatric low-grade glioma (pLGG) includes volumetric assessment, more simplified 2D-based methods are often used in clinical trials. The study's purpose was to compare volumetric to 2D...
6.
Ramakrishnan D, Ilagan-Ying Y, Bollinger B, Dunne D
South Med J . 2023 Dec; 117(1):1-6. PMID: 38151243
Objectives: Transitioning from classroom learning to clerkships presents a challenge for medical students because there is often sparse preparation material on how to effectively contribute to the medical team as...
7.
Tillmanns N, Lost J, Tabor J, Vasandani S, Vetsa S, Marianayagam N, et al.
Sci Rep . 2023 Dec; 13(1):22942. PMID: 38135704
Gliomas with CDKN2A mutations are known to have worse prognosis but imaging features of these gliomas are unknown. Our goal is to identify CDKN2A specific qualitative imaging biomarkers in glioblastomas...
8.
Haas-Kogan D, Aboian M, Minturn J, Leary S, Abdelbaki M, Goldman S, et al.
J Clin Oncol . 2023 Nov; 42(4):441-451. PMID: 37978951
Purpose: The PNOC001 phase II single-arm trial sought to estimate progression-free survival (PFS) associated with everolimus therapy for progressive/recurrent pediatric low-grade glioma (pLGG) on the basis of phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian...
9.
Ramakrishnan D, von Reppert M, Krycia M, Sala M, Mueller S, Aneja S, et al.
Neurooncol Adv . 2023 Oct; 5(1):vdad118. PMID: 37860269
Radiographic response assessment in neuro-oncology is critical in clinical practice and trials. Conventional criteria, such as the MacDonald and response assessment in neuro-oncology (RANO) criteria, rely on bidimensional (2D) measurements...
10.
Ramakrishnan D, Jekel L, Chadha S, Janas A, Moy H, Maleki N, et al.
ArXiv . 2023 Sep; PMID: 37744461
Resection and whole brain radiotherapy (WBRT) are the standards of care for the treatment of patients with brain metastases (BM) but are often associated with cognitive side effects. Stereotactic radiosurgery...